BVF PARTNERS L P/IL
Insider trading activity for BVF PARTNERS L P/IL sourced from SEC EDGAR Form 4 filings.
Overview
- Company: IMMUNIC, INC.
- Total insider trades: 19
- Total buy volume: $0
- Total sell volume: $236.6M
- Last trade: Sep 18, 2026
Recent Trades
| Date | Insider | Ticker / Company | Type | Shares | Value |
|---|---|---|---|---|---|
| Sep 16, 2026 | BVF PARTNERS L P/IL | IMUX IMMUNIC, INC. | OTHER | 25,370 | N/A |
| Jun 26, 2026 | BVF PARTNERS L P/IL | KYMR Kymera Therapeutics, Inc. | SELL | 51,858 | $5.5M |
| Jun 26, 2026 | BVF PARTNERS L P/IL | KYMR Kymera Therapeutics, Inc. | SELL | 113,289 | $12.1M |
| Jun 26, 2026 | BVF PARTNERS L P/IL | KYMR Kymera Therapeutics, Inc. | SELL | 627,597 | $66.8M |
| Jun 26, 2026 | BVF PARTNERS L P/IL | KYMR Kymera Therapeutics, Inc. | SELL | 837,914 | $89.2M |
| Jun 24, 2026 | BVF PARTNERS L P/IL | KYMR Kymera Therapeutics, Inc. | OTHER | 6,068 | N/A |
| Jun 18, 2026 | BVF PARTNERS L P/IL | OLMA Olema Pharmaceuticals, Inc. | OTHER | 29,500 | N/A |
| Jun 17, 2026 | BVF PARTNERS L P/IL | MLTX MoonLake Immunotherapeutics | OTHER | 22,195 | N/A |
| May 14, 2026 | BVF PARTNERS L P/IL | XOMA XOMA Royalty Corp | OTHER | 772 | N/A |
| May 14, 2026 | BVF PARTNERS L P/IL | XOMA XOMA Royalty Corp | OTHER | 412 | N/A |
| May 14, 2026 | BVF PARTNERS L P/IL | XOMA XOMA Royalty Corp | OTHER | 1,506 | N/A |
| May 14, 2026 | BVF PARTNERS L P/IL | XOMA XOMA Royalty Corp | OTHER | 2,313 | N/A |
| May 14, 2026 | BVF PARTNERS L P/IL | XOMA XOMA Royalty Corp | OTHER | 772,000 | $3.1M |
| May 14, 2026 | BVF PARTNERS L P/IL | XOMA XOMA Royalty Corp | OTHER | 412,000 | $1.7M |
| May 14, 2026 | BVF PARTNERS L P/IL | XOMA XOMA Royalty Corp | OTHER | 1,506,000 | $6.1M |
| May 14, 2026 | BVF PARTNERS L P/IL | XOMA XOMA Royalty Corp | OTHER | 2,313,000 | $9.3M |
| Mar 31, 2026 | BVF PARTNERS L P/IL | MLTX MoonLake Immunotherapeutics | SELL | 248,530 | $4.2M |
| Mar 31, 2026 | BVF PARTNERS L P/IL | MLTX MoonLake Immunotherapeutics | SELL | 1,569,116 | $26.3M |
| Mar 31, 2026 | BVF PARTNERS L P/IL | MLTX MoonLake Immunotherapeutics | SELL | 1,932,354 | $32.4M |